Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1983-12-20
1985-10-08
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
435235, 435238, A61K 3912
Patent
active
045459878
ABSTRACT:
Novel vaccines of double-stranded RNA viruses are prepared by psoralen inactivation under mild conditions in an inert atmosphere, optionally in the presence of a mild singlet oxygen scavenger. The resulting inactivated virus can be used as a vaccine for inoculation of hosts to provide for the stimulation of the immune system to the virus.
REFERENCES:
Theiler, Vet. J., (1980), 64:600-607.
Kemeny and Drehle, Am. J. Vet. Res., (1961), 22:921-925.
Alexander and Haig, Onderstepoort J. Vet. Res., (1951), 25:3-15.
Parker et al., Vet. Rec., (1975), 96:284-287.
Isaacs et al., Biochemistry, (1977), 16:1058-1064.
Hearst and Thiry, Nucleic Acids Res., (1977), 4:1339-1347.
Hanson et al., J. Gen. Virol., (1978), 40:345-358.
Talib and Banerjee, Virology, (1982), 118:430-438.
Hanson, Medical Virology II, Proceedings of the 1982 International Symposium on Medical Virology, de la Maza and Peterson, eds., New York: Elsevier Biomedical, 1983, pp. 45-75.
J. Parker et al., (1975), Vet. Rec. 96:284-287.
J. L. Stott, et al., (1979), Proc. Annu. Meet US Anim Health Assoc., 177:55-62.
B. I. Osburn et al., and J. L. Stott et al., (1979), Fed. Proc. 38 (3 part 1) 1091 Coden: FEPRA.
Giles Richard E.
Stevens David R.
Wiesehahn Gary P.
Advanced Genetics Research Institute
Rose Shep K.
LandOfFree
Psoralen inactivated double-stranded RNA viral vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Psoralen inactivated double-stranded RNA viral vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Psoralen inactivated double-stranded RNA viral vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2219202